Short answer: In US law, "research use only" is a labeling phrase defined for in vitro diagnostic products: test kits and reagents used on samples in a lab. It is not a legal category for injectable peptides. FDA decides whether something is a drug by its intended use, judged from the seller's website, claims and the circumstances of sale, not by a disclaimer. In 2026 FDA warning letters, the agency said that despite labels reading "for research use only" and "not for human or veterinary use," the sellers' websites showed the products were drugs for human use, and it even called the bacteriostatic water sold with them a drug. For buyers, the practical meaning is simple: no one has checked what is in the vial.
Many peptides sold online carry a line like "For research use only. Not for human consumption." Buyers often read it as a legal workaround: the seller is covered, and the product is technically allowed. This article explains what the phrase actually means in US law, using the statute, FDA's regulations and FDA's own warning letters. It is general information, not legal advice.
The phrase has a specific home in FDA's rules, and it is not peptides. Under 21 CFR 809.10(c), an in vitro diagnostic product that is still in the lab research phase, "and not represented as an effective in vitro diagnostic product," can skip normal labeling rules if all its labeling bears the statement: "For Research Use Only. Not for use in diagnostic procedures."
In vitro diagnostic products are defined in 21 CFR 809.3 as reagents, instruments and systems used to examine "specimens taken from the human body" (blood tests, for example). They are devices used on samples in a lab. A vial of peptide meant to be injected into a person is not an in vitro diagnostic, so this exemption does not apply to it.
The Federal Food, Drug, and Cosmetic Act defines a drug in section 201(g)(1) (21 U.S.C. 321(g)(1)). Among other things, a drug includes "articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease" and "articles (other than food) intended to affect the structure or any function of the body."
The key word is intended. FDA's regulation on intended use, 21 CFR 201.128, says intended use means "the objective intent" of the people responsible for the product. That intent can be shown by their "expressions, the design or composition of the article, or by the circumstances surrounding the distribution of the article," including "labeling claims, advertising matter, or oral or written statements." So the question FDA asks is not "what does the small print say?" but "what is this obviously being sold for?"
FDA has sent a run of warning letters to online peptide sellers. We read one issued on August 24, 2026 by FDA's Center for Drug Evaluation and Research to an online seller of peptides including SS-31, tesamorelin and PT-141. We are not naming sellers here; the letter is linked in the sources. Its main points:
FDA's warning letter pages show similar letters to other online peptide sellers in December 2024, December 2025, March 2026, June 2026 and August 2026. A warning letter is FDA's formal notice of violations. FDA says failure to fix them may lead to action such as seizure or injunction.
The law above is aimed at sellers. For a buyer, the practical meaning is about quality, not legality:
A compounded drug from a state-licensed pharmacy, prescribed for you, follows a different set of rules (section 503A). Compounded drugs are not FDA-approved either, but the pharmacy must use ingredients that meet one of three conditions, including an FDA-registered source and a valid certificate of analysis. Many popular peptides do not meet those conditions today. Our compounding explainer walks through which ones and why.
Talk to a licensed clinician before using any peptide, and prefer FDA-approved or properly prescribed products where they exist. If you track a product of uncertain origin, record the seller, lot number, the COA you received, the reconstitution date and every dose. If something goes wrong, that record is what you and your clinician will need, and FDA accepts reports through MedWatch. Dose Track keeps vial, lot and dose history together, and you can export it.
Questions about the app? See the help center or join the Dose Track community.
Every number in this article comes from one of these sources, checked on October 22, 2026. This article is for education. It is not medical or legal advice, and nothing here is a dose recommendation.